ZHANG Yong-Ming,LIU Xiu-Yun. Advance in the diagnosis and treatment of Mycoplasma pneumoniae pneumonia and related complications[J]. CJCP, 2011, 13(4): 358-360.
［1］Youn YS, Lee KY, Hwang JY, Rhim JW, Kang JH, Lee JS, et al. Difference of linical featues in childhood Mycoplasma pneumoniae pniumonia［J］. BMC Pediatr, 2010, 10: 48.
［2］Michelow IC, Olsen K, Lozano J, Rollins NK, Duffy LB, Ziegler T, et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children［J］.Pediatrics, 2004, 113(4): 701-707.
［3］Fischer JE, Steiner F, Zucol F, Berger C, Martignon L, Bossart W, et al. Use of simple heuristics to target macrolide prescription in children with community-acquired pneumonia［J］.Arch Pediatr Adolesc Med, 2002, 156(10): 1005-1008.
［8］V-zquez JL, V-zquez I, Gonz-lez ML, García Tejedor JL, Rep-raz A. Pneumomediastinum and pneumothorax as presenting signs in severe Mycoplasma pneumoniae pneumonia［J］.Pediatr Radiol, 2007, 37(12): 1286-1288.
［9］Wang RS, Wang SY, Hsieh KS, Chiou YH, Huang IF, Cheng MF, et al. Necrotizing pneumonitis caused by mycoplasma pneumoniae in pediatric patients report of five cases and review of literature［J］. Pediatr Infect Dis J, 2004, 23(6): 564-567.
［10］Kim CK, Chung CY, Kim JS, Kim WS, Park Y, Kou YY. Late abnormal findings on high-resolution computed tomography after Mycoplasma pneumonia［J］. Pediatrics, 2000, 105(2): 372-378.
［11］Isles AF, Masel J, O′Duffy J. Obliterative bronchiolitis due to Mycoplasma pneumoniae infection in a child［J］. Pediatr Radiol,1987,17(2):109-111.
［13］Stokes D, Sigler A, Khouri NF, Talamo RC. Unilateral hyperlucent lung (Swyer-James syndrome) after severe Mycoplasma pneumoniae infection［J］.Am Rev Respir Dis, 1978, 117(1): 145-152.
［14］Wachowski O, Demirakca S, Müller KM, Scheurlen W. Mycoplasma pneumoniae associated organising pneumonia in a 10 year old boy［J］.Arch Dis Child, 2003, 88(3): 270-272.
［15］Tablan OC, Reyes MP. Chronic interstitial pulmonary fibrosis following mycoplasma pneumoniae pneumonia［J］. Am J Med, 1985, 79(2): 268-270.
［16］Biscardi S, Lorrot M, Marc E, Moulin F, Boutonnat-Faucher B, Heibronner C, et al. Mycoplasma pneumoniae and asthma in children［J］. Clin Infect Dis, 2004, 38(10):1341-1346.
［17］Sabato AR, Martin AJ, Marmion BP, Kok TW, Cooper DM. Mycoplasma pneumoniae: acute illness, antibiotics, and subsequent pulmonary function［J］. Arch Dis Child, 1984, 59(11): 1034-1037.
［18］Marc E, Chaussain M, Moulin F, Iniguez JL, Kalifa G, Raymond J, et al. Reduced lung diffusion capacity after mycoplasma pneumoniae pneumonia［J］. Pediatr Infect Dis J, 2000, 19(8): 706-710.
［19］Todisco T, de Benedictis FM, Dottorini M. Viral and Mycoplasma pneumoniae pneumonias in school-age children: three-year follow-up of respiratory function［J］. Pediatr Pulmonol, 1989, 6(4): 232-236.
［23］Lee KY, Lee HS, Hong JH, Lee MH, Lee JS, Burgner D, et al. Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children［J］. Pediatr Pulmonl, 2006, 41(3): 263-268.
［25］Iwata A, Izumikawa K, Sekita T, Ishimoto H, Sakamoto N, Nakayama S, et al. A case of mycoplasmal pneumonia with bronchiolitis treated with steroids［J］. Kansenshogaku Zasshi, 2007, 81(5): 586-591.
